“Treatment with the soluble guanylyl cyclase inhibitor ODQ (100% for carrageenan and … PGE2; 8 µg/paw) and the ATP-sensitive K+ channel (KATP) blocker glibenclamide (87.…% for carrageenan and 100% for PGE2; 160 µg/paw) reversed the antinociceptive effect … tumor bearing in a statistically significant manner (P < 0.05).”